Long intracellular retention of 4′-thio-arabinofuranosylcytosine 5′-triphosphate as a critical factor for the anti-solid tumor activity of 4′-thio-arabinofuranosylcytosine
Autor: | Hitoshi Someya, William B. Parker, William R. Waud |
---|---|
Rok vydání: | 2005 |
Předmět: |
Cancer Research
Cytidine Triphosphate Antineoplastic Agents Biology Toxicology Cell Line Tumor medicine Humans Pharmacology (medical) Cytosine analog Cell Proliferation Pharmacology Arabinonucleotides Cell growth Cytarabine Biological activity DNA Deoxycytidine kinase Cytidine deaminase carbohydrates (lipids) Oncology Mechanism of action Biochemistry Deoxycytidylate Deaminase Arabinonucleosides medicine.symptom Intracellular Half-Life |
Zdroj: | Cancer Chemotherapy and Pharmacology. 57:772-780 |
ISSN: | 1432-0843 0344-5704 |
DOI: | 10.1007/s00280-005-0126-0 |
Popis: | 4'-Thio-arabinofuranosylcytosine (T-araC) is a new cytosine analog, which exhibits excellent antitumor activity against various solid tumor xenografts in mice. T-araC is a structural analog of arabinofuranosylcytosine (araC), which is known to be marginally active against solid tumors. We have continued to study the biochemical pharmacology of T-araC in solid tumor cells to further characterize the mechanism of action of this new agent and to elucidate why these compounds show a profound difference in antitumor activity against solid tumors. AraC was a slightly more potent inhibitor of cell growth than T-araC when cells were continuously exposed to the drugs. However, T-araC was markedly more cytotoxic than araC when high concentrations of the compounds were given for short periods of time. Despite the fact that T-araC is a much poorer substrate, as compared to araC, for deoxycytidine kinase (the rate-limiting step in the formation of the triphosphates), similar intracellular concentrations of T-araC-5'-triphosphate (T-araCTP) and araCTP were formed in cells at these high, pharmacologically relevant concentrations due to similar Vmax's. The major difference in the metabolism of araC and T-araC was that the half-life of T-araCTP was tenfold longer than that of araCTP and much higher levels of T-araCTP were sustained in cells for long durations after exposure to T-araC. Inhibition of cytidine deaminase, deoxycytidylate deaminase, or DNA replication did not affect the half-life of either araCTP or T-araCTP. In addition, the rates of disappearance of the mono- and tri-phosphates of araC and T-araC in crude cell extracts were similar. These results indicated that these enzymes were not rate-limiting in the degradation of the respective triphosphates. However, the rate of phosphorylation of T-araC-5'-monophosphate (T-araCMP) in crude cell extracts was about tenfold greater than that of araCMP. The results of this work suggested that the longer intracellular retention of T-araCTP was responsible for the superior activity of T-araC against solid tumors in vivo, and that the greater activity of T-araCMP as a substrate of UMP/CMP kinase was responsible for the long intracellular half-life of T-araCTP. |
Databáze: | OpenAIRE |
Externí odkaz: |